OpenEvidence logo

OpenEvidence

Emerging

OpenEvidence hit $100M+ ARR in under a year serving 430K+ US physicians (40% of all US doctors) at $12B valuation ($700M raised); fastest-growing physician AI platform, founded 2022 Miami.

Best for: AI Clinical EvidenceEmerging, rapid growth
41
AI Score
Grade C↑ Trending
AI Visibility Score (Beta)
HealthcareAI Clinical EvidenceWebsiteUpdated April 2026

Brand Intelligence Graph

Capabilities
AI Clinical Evidence

Company Overview

About OpenEvidence

OpenEvidence is an AI clinical evidence platform founded in 2022 and headquartered in Miami, Florida. Built specifically for physicians, the platform applies large language models trained on peer-reviewed medical literature to deliver instant, evidence-backed answers to clinical questions at the point of care. Its founding mission is to democratize access to the best available medical evidence so that every physician can practice at the highest standard, regardless of institution or specialty.

Business Model & Competitive Advantage

The platform aggregates and synthesizes peer-reviewed studies, clinical guidelines, and drug databases, presenting structured answers with citations that meet physician-grade accuracy standards. Unlike general-purpose AI assistants, OpenEvidence is purpose-built for clinical workflows. It is free to use for physicians, with monetization routed through pharmaceutical and healthcare industry partners who value the platform's direct access to practicing clinicians.

Competitive Landscape 2025–2026

OpenEvidence has achieved remarkable traction, reaching over 430,000 US physicians — approximately 40% of the entire US physician population — making it the fastest-growing physician AI platform on record. The company crossed $100M ARR in under a year from launch and earned a $12 billion valuation on $700 million in total funding. This trajectory places OpenEvidence among the fastest-scaling healthcare AI companies globally and signals a structural shift toward AI-assisted clinical decision-making at the point of care.

Founded
2022
Headquarters
Miami, Florida
Revenue
$100M
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

OpenEvidence is an emerging player bringing innovative solutions to the Healthcare Tech market.

Growth Stage

OpenEvidence has achieved $100M in revenue, demonstrating strong product-market fit.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

41
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

GE HealthCare logo

GE HealthCare

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin

Incyte logo

Incyte

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,

For OpenEvidence

Claim This Profile

Are you from OpenEvidence? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim OpenEvidence Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention OpenEvidence vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →